biopharma, Investments, News, sisaf, Startups, vickers venture partners

Vickers Venture Partners leads $13.2m series B round in UK biotech startup

SiSaf will use funds from the financing round to treat rare genetic bone and eye conditions.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

1 × 1 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.